GSK Faces Whistleblower Suit From Lab That Found Zantac Risk bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.
GSK Plc. is facing a whistleblower lawsuit that could potentially cost it billions of dollars from the laboratory that revealed the presence of a probable carcinogen in Zantac, the heartburn medication that the UK drugmaker invented and turned into a blockbuster. An amended complaint filed Monday contends that GSK hid…
Bayer Taps Activist Investor Jeffrey Ubben for Supervisory Board bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.
(Bloomberg) — Bayer AG plans to add activist investor Jeffrey Ubben to its supervisory board in the latest shakeup at the troubled chemicals and drugs company before a capital markets event next week. Ubben, the founder of Inclusive Capital Partners in California, is one of three new independent candidates that the German company will propose…
Bayer Taps Activist Investor Jeffrey Ubben for Supervisory Board swissinfo.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from swissinfo.ch Daily Mail and Mail on Sunday newspapers.